Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 19, 2022
Good and surprising news finds germline mutations are rare in low-risk prostate cancer
From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
Access to Prostate Cancer Clinical Trials: A County-Level Analysis
From the Bansal Group, Public Health Sciences Division
Genomic attributes predict cancer treatment responsiveness
From the Nelson Lab, Human Biology & Clinical Research Divisions
Dr. Andrew Hsieh elected member of American Society for Clinical Investigation
Physician-scientist demonstrated central role protein synthesis plays in cancer
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Computational predictions reveal an unexpected synergy for prostate cancer therapy
From the Gujral Lab, Human Biology Division
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Building better lab models of human tumors
Dr. John Lee receives $1.5M NIH New Innovator Award for creative young scientists with high-risk, high-reward projects
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Untranslated, maybe, unappreciated, no more.
From the Hsieh Lab, Human Biology Division
Overlooked stretches of DNA could hide cancer-causing mutations
New cutting-edge technique sheds light on difficult-to-study DNA regions, potential drug targets
Catching up with cancer as COVID-19 starts to ebb
Public health researchers scramble to get preventive cancer screenings back on peoples’ radar – and calendars – as cases dwindle and restrictions lift
Prostate cancer researcher Dr. Janet Stanford retires after three decades
Career of discoveries about prostate cancer genetics, risks, outcomes
Dr. Yingye Zheng named fellow of American Statistical Association
Honored for work to develop biomedical decision tools
Projection of cancer screening on metastasis: A prostate cancer case study
From the Etzioni Group, Public Health Sciences Division
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Summaries of recent Fred Hutch research findings and other news, plus resources for the American Society of Hematology’s annual meeting
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Comparing sexual quality of life among survivors of prostate, bladder, colorectal, and lung cancer
From the Ramsey Group, Public Health Sciences Division
Dr. Ruth Etzioni receives Rosalie & Harold Rea Brown Endowed Chair
'Biostatistician on a mission' uses math models to improve cancer screening, reduce health disparities
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.